FdaApplication
ANDA 210716
Identifiers
- fda_app_no: ANDA210716
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL RX SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2020-12-29 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TADALAFIL | TADALAFIL | 2.5MG | TABLET;ORAL |
| TADALAFIL | TADALAFIL | 5MG | TABLET;ORAL |
| TADALAFIL | TADALAFIL | 20MG | TABLET;ORAL |
| TADALAFIL | TADALAFIL | 10MG | TABLET;ORAL |
4 products